Group One Trading, L.P. Crispr Therapeutics Ag Transaction History

Group One Trading, L.P.

  • $3.01 Billion
  • Q2 2024

A detailed history of Group One Trading, L.P. transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Group One Trading, L.P. holds 68,490 shares of CRSP stock, worth $3.55 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares
68,490
Previous 23,553 190.79%
Holding current value
$3.55 Million
Previous $1.61 Million 130.47%
% of portfolio
0.12%
Previous 0.06%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$51.17 - $68.18 $2.3 Million - $3.06 Million
44,937 Added 190.79%
68,490 $3.7 Million
Q1 2024

May 10, 2024
BUY
$60.67 - $89.12 $1.43 Million - $2.1 Million
23,553 New
23,553 $1.61 Million
Q3 2023

Nov 09, 2023
SELL
$45.39 - $59.0 $470,331 - $611,358
-10,362 Reduced 14.0%
63,677 $2.89 Million
Q2 2023

Aug 09, 2023
BUY
$43.47 - $67.77 $1.2 Million - $1.87 Million
27,642 Added 59.58%
74,039 $4.16 Million
Q1 2023

May 12, 2023
BUY
$41.0 - $56.12 $20,213 - $27,667
493 Added 1.07%
46,397 $2.1 Million
Q4 2022

Feb 09, 2023
BUY
$39.19 - $65.67 $1.53 Million - $2.56 Million
39,058 Added 570.52%
45,904 $1.87 Million
Q3 2022

Nov 09, 2022
SELL
$61.1 - $83.78 $7.88 Million - $10.8 Million
-128,901 Reduced 94.96%
6,846 $447,000
Q2 2022

Aug 11, 2022
SELL
$43.23 - $73.83 $3.88 Million - $6.63 Million
-89,772 Reduced 39.81%
135,747 $8.25 Million
Q1 2022

May 12, 2022
SELL
$53.19 - $79.24 $13.5 Million - $20.1 Million
-253,278 Reduced 52.9%
225,519 $14.2 Million
Q4 2021

Feb 11, 2022
BUY
$70.09 - $111.29 $13.1 Million - $20.8 Million
186,961 Added 64.06%
478,797 $36.3 Million
Q3 2021

Nov 12, 2021
SELL
$110.2 - $156.64 $11.9 Million - $16.9 Million
-107,911 Reduced 26.99%
291,836 $32.7 Million
Q2 2021

Aug 10, 2021
BUY
$100.84 - $161.89 $2.3 Million - $3.7 Million
22,853 Added 6.06%
399,747 $64.7 Million
Q1 2021

May 12, 2021
BUY
$110.72 - $210.04 $34.2 Million - $65 Million
309,254 Added 457.21%
376,894 $45.9 Million
Q4 2020

Feb 10, 2021
BUY
$79.67 - $173.23 $5.39 Million - $11.7 Million
67,640 New
67,640 $10.4 Million
Q1 2019

May 13, 2019
SELL
$28.02 - $40.87 $65,734 - $95,881
-2,346 Closed
0 $0
Q4 2018

Feb 06, 2019
SELL
$22.73 - $42.34 $789,367 - $1.47 Million
-34,728 Reduced 93.67%
2,346 $67,000
Q3 2018

Nov 08, 2018
BUY
$44.35 - $65.71 $1.27 Million - $1.89 Million
28,713 Added 343.42%
37,074 $1.64 Million
Q2 2018

Aug 14, 2018
SELL
$42.62 - $73.59 $248,559 - $429,176
-5,832 Reduced 41.09%
8,361 $491,000
Q1 2018

May 11, 2018
BUY
$23.52 - $58.17 $304,160 - $752,254
12,932 Added 1025.54%
14,193 $649,000
Q4 2017

Feb 09, 2018
BUY
$16.95 - $23.48 $21,373 - $29,608
1,261
1,261 $30,000

Others Institutions Holding CRSP

# of Institutions
503
Shares Held
57.1M
Call Options Held
1.74M
Put Options Held
1.83M
View Full List

About CRISPR Therapeutics AG

CRSP Quotes by TradingView
  • Ticker CRSP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,009,296
  • Market Cap $4.05B
  • Description
  • CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....
More about CRSP
Track This Portfolio

Track Group One Trading, L.P. Portfolio

Follow Group One Trading, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email